Vivo Capital, LLC Crinetics Pharmaceuticals, Inc. Transaction History

Vivo Capital, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$15.97 - $30.59 $5.59 Million - $10.7 Million	350,000 New	350,000 $10.4 Million
Q4 2021 Feb 11, 2022	SELL	$19.35 - $28.41 $10 Million - $14.7 Million	-517,280 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$16.88 - $25.23 $20.8 Million - $31.2 Million	-1,235,066 Reduced 70.48%	517,280 $10.9 Million
Q2 2021 Aug 16, 2021	SELL	$15.9 - $21.15 $7.34 Million - $9.77 Million	-461,792 Reduced 20.86%	1,752,346 $33 Million
Q1 2021 May 17, 2021	SELL	$13.3 - $17.55 $1.62 Million - $2.14 Million	-121,751 Reduced 5.21%	2,214,138 $33.8 Million
Q4 2020 Feb 16, 2021	BUY	$12.08 - $17.46 $871,197 - $1.26 Million	72,119 Added 3.19%	2,335,889 $33 Million
Q3 2020 Nov 13, 2020	SELL	$13.62 - $17.66 $719,925 - $933,472	-52,858 Reduced 2.28%	2,263,770 $35.5 Million
Q2 2020 Aug 14, 2020	SELL	$13.04 - $23.23 $13.1 Million - $23.3 Million	-1,004,173 Reduced 30.24%	2,316,628 $40.6 Million
Q1 2020 May 15, 2020	BUY	$11.52 - $26.46 $38.3 Million - $87.9 Million	3,320,801 New	3,320,801 $48.8 Million
Q3 2019 Nov 13, 2019	SELL	$14.91 - $25.01 $50.3 Million - $84.4 Million	-3,375,169 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$21.07 - $29.31 $8.79 Million - $12.2 Million	-417,000 Reduced 11.0%	3,375,169 $76.8 Million
Q3 2018 Nov 13, 2018	BUY	$22.66 - $36.8 $85.9 Million - $140 Million	3,792,169 New	3,792,169 $109 Million

254

82.5M

26.1K

11.8K

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $1.89B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.